◀ Back to MAPK3

BTRC — MAPK3

Text-mined interactions from Literome

Bondzi et al., Cell Growth Differ 2000 (Carcinoma, Small Cell...) : In the present study, we have demonstrated that PP1, a pharmacological inhibitor of Src kinases, blocked SCF mediated activation of mitogen activated protein ( MAP ) kinase , but it also inhibited Kit activation
Krystal et al., Clin Cancer Res 2000 (Carcinoma, Small Cell...) : STI571 efficiently blocked SCF mediated activation of mitogen activated protein kinase and Akt, but did not affect insulin-like growth factor-1 or serum mediated mitogen activated protein kinase or Akt activation
Jacobs-Helber et al., J Biol Chem 1997 (Leukemia, Erythroblastic, Acute) : SCF induced proliferation, SHC phosphorylation, and activation of ERK-1 but did not activate the JAK/STAT pathway ... SCF stimulated SHC phosphorylation and ERK-1 activation independent of the EPOR in cells where the EPOR was down-regulated ; the presence of the EPOR appeared to facilitate SCF activation of SHC and ERK-1